Clinical Outcomes of Patients With Atrial Septal Defect and Pulmonary Arterial Hypertension

Background Indications for atrial septal defect (ASD) closure in patients with pulmonary arterial hypertension (PAH) have not been established. We evaluated medium-term outcomes in such patients with regard to the effect of ASD closure and prognostic predictors. Methods This single-center retrospective study included 39 patients with pulmonary vascular resistance (PVR) ≥ 2 Wood units (WU). The primary adverse outcome was defined as a composite of major cardiovascular events, including cardiac death or hospitalization for heart failure. Results Of the 39 patients, 32 underwent shunt closure, whereas 7 did not. Among patients with PVR ≥ 5 WU, over a median follow-up of 3.8 years, 3-year clinical event rates were 27.3% (3/11) in the closure group ( n = 11) and 14.3% (1/7) in the no-closure group ( n = 7); the difference was not statistically significant. The maximal velocity of tricuspid regurgitation significantly decreased during follow-up in the closure group; no significant change was observed in the no-closure group. In patients with PVR ≥ 5 WU, systemic arterial oxygen saturation (SaO 2 ) showed a significant association with the primary composite outcome; ASD closure and PVR were not. Among patients with PVR ≥ 5 WU who underwent ASD closure, those with SaO 2 < 93% ( n = 4) had a significantly higher rate of adverse outcomes than those with SaO 2 ≥ 93% ( n = 7) (hazard ratio, 17.8; P = .014), whereas no composite adverse events occurred in patients with SaO 2 ≥ 93%. Conclusions In patients with ASD and severe PAH, SaO 2 < 93% showed a significant association with adverse outcomes and may complement PVR in risk stratification. These exploratory findings require prospective validation.

Authors

Institutions

Publication Details

Journal
World Journal for Pediatric and Congenital Heart Surgery
Published
2026-11-13
DOI
https://doi.org/10.1177/21501351261501185
Primary Topic
Cardiovascular and Diving-Related Complications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Clinical Outcomes of Patients With Atrial Septal Defect and Pulmonary Arterial Hypertension

Sahmin Lee, Pil Hyung Lee, Jong‐Min Song, Duk Hyun Kang et al.
2 links
World Journal for Pediatric and Congenital Heart Surgery
Cardiovascular and Diving-Related Complications
article

Clinical Outcomes of Patients With Atrial Septal Defect and Pulmonary Arterial Hypertension

Sahmin Lee, Pil Hyung Lee, Jong‐Min Song, Duk Hyun Kang, Jae-Kwan Song, Dae-Hee Kim, Dayoung Baek, Byung Joo Sun
article en

Abstract

Background Indications for atrial septal defect (ASD) closure in patients with pulmonary arterial hypertension (PAH) have not been established. We evaluated medium-term outcomes in such patients with regard to the effect of ASD closure and prognostic predictors. Methods This single-center retrospective study included 39 patients with pulmonary vascular resistance (PVR) ≥ 2 Wood units (WU). The primary adverse outcome was defined as a composite of major cardiovascular events, including cardiac death or hospitalization for heart failure. Results Of the 39 patients, 32 underwent shunt closure, whereas 7 did not. Among patients with PVR ≥ 5 WU, over a median follow-up of 3.8 years, 3-year clinical event rates were 27.3% (3/11) in the closure group ( n = 11) and 14.3% (1/7) in the no-closure group ( n = 7); the difference was not statistically significant. The maximal velocity of tricuspid regurgitation significantly decreased during follow-up in the closure group; no significant change was observed in the no-closure group. In patients with PVR ≥ 5 WU, systemic arterial oxygen saturation (SaO 2 ) showed a significant association with the primary composite outcome; ASD closure and PVR were not. Among patients with PVR ≥ 5 WU who underwent ASD closure, those with SaO 2 < 93% ( n = 4) had a significantly higher rate of adverse outcomes than those with SaO 2 ≥ 93% ( n = 7) (hazard ratio, 17.8; P = .014), whereas no composite adverse events occurred in patients with SaO 2 ≥ 93%. Conclusions In patients with ASD and severe PAH, SaO 2 < 93% showed a significant association with adverse outcomes and may complement PVR in risk stratification. These exploratory findings require prospective validation.

World Journal for Pediatric and Congenital Heart Surgery
University of Ulsan (KR)
Good health and well-being
Cardiovascular and Diving-Related Complications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon